Skip to content

A nutrition and lifestyle intervention in patients with PuLmonary Arterial Hypertension: effect on quality of life

A nutrition and lifestyle intervention in patients with PuLmonary Arterial Hypertension: effect on quality of life - UPHILL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON48646
Enrollment
70
Registered
2019-07-30
Start date
2019-10-25
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high blood pressure in the pulmonary arteriole Pumonary Arterial Hypertension

Interventions

Every subject will have the option to wear a Fitbit during this study, and than has to wear it day and night, during the entire study. With the Fitbit we want to track the general wellbeing: daily e

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Diagnoses of idiopathic PAH, hereditary PAH or drug related PAH Age between 18 and 80 NYHA II or III and stable for at least three months, measured with 6MWT 30 ml/min Able to understand and willing to sign the Informed Consent Form

Exclusion criteria

Exclusion criteria: Pregnant subjects Fat percentage 55% One or more of the following comorbidities: diabetes mellitus type one or two, clinical relevant hypothyroid Known history of noncompliance considering therapies

Design outcomes

Primary

MeasureTime frame
To explore the effect of a nutrition and lifestyle intervention for PAH-patients on quality of life.

Secondary

MeasureTime frame
- Perform a systematic analyses of nutritional status. Is nutritional status associated with clinical worsening or RV function in PAH? - Determine the effect of nutritional education alone, and the additional effect of a nutritional intervention in PAH. - Determine which nutritional intervention is most effective. Which diet is associated with the largest improvement in quality of life and best compliance in PAH?

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)